BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 17936695)

  • 1. Monitoring phospholipids for assessment of matrix effects in a liquid chromatography-tandem mass spectrometry method for hydrocodone and pseudoephedrine in human plasma.
    Ismaiel OA; Halquist MS; Elmamly MY; Shalaby A; Karnes HT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Nov; 859(1):84-93. PubMed ID: 17936695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring phospholipids for assessment of ion enhancement and ion suppression in ESI and APCI LC/MS/MS for chlorpheniramine in human plasma and the importance of multiple source matrix effect evaluations.
    Ismaiel OA; Halquist MS; Elmamly MY; Shalaby A; Thomas Karnes H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Nov; 875(2):333-43. PubMed ID: 18926779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipids in liquid chromatography/mass spectrometry bioanalysis: comparison of three tandem mass spectrometric techniques for monitoring plasma phospholipids, the effect of mobile phase composition on phospholipids elution and the association of phospholipids with matrix effects.
    Xia YQ; Jemal M
    Rapid Commun Mass Spectrom; 2009 Jul; 23(14):2125-38. PubMed ID: 19517478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of endogenous blood plasma phospholipids, cholesterol and glycerides that contribute to matrix effects in bioanalysis by liquid chromatography/mass spectrometry.
    Ismaiel OA; Zhang T; Jenkins RG; Karnes HT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(31):3303-16. PubMed ID: 21056019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a selective and sensitive bioanalytical procedure for the quantitative determination of gaboxadol in human plasma employing mixed mode solid phase extraction and hydrophilic interaction liquid chromatography with tandem mass spectroscopic detection.
    Kall MA; Fu I; Dige T; Vallano P; Woolf E; Jørgensen M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):168-76. PubMed ID: 17851145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of triprolidine and pseudoephedrine in human plasma by liquid chromatography-ion trap mass spectrometry.
    Shakya AK; Arafat TA; Abuawwad AN; Melhim M; Al-Ghani J; Yacoub MJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec; 877(32):4071-8. PubMed ID: 19926351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of matrix effects and determination of niacin in human plasma using liquid-liquid extraction and liquid chromatography-tandem mass spectrometry.
    Peoples MC; Halquist MS; Ismaiel O; El-Mammli MY; Shalaby A; Karnes HT
    Biomed Chromatogr; 2008 Nov; 22(11):1272-8. PubMed ID: 18651588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative method for analysis of hydrocodone, hydromorphone and norhydrocodone in human plasma by liquid chromatography-tandem mass spectrometry.
    Valtier S; Mueck RL; Bebarta VS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 925():40-5. PubMed ID: 23523877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses.
    Chambers E; Wagrowski-Diehl DM; Lu Z; Mazzeo JR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):22-34. PubMed ID: 17236825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative determination of zidovudine diaryl phosphate triester pro-drugs in rat plasma by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry.
    Zhu M; Xie B; Tang G; Hu A; Fang M; Wu Z; Zhao Y
    J Pharm Biomed Anal; 2008 Dec; 48(5):1417-24. PubMed ID: 19118970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel strategy for reducing phospholipids-based matrix effect in LC-ESI-MS bioanalysis by means of HybridSPE.
    Pucci V; Di Palma S; Alfieri A; Bonelli F; Monteagudo E
    J Pharm Biomed Anal; 2009 Dec; 50(5):867-71. PubMed ID: 19553055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validated quantitation of angiotensin II receptor antagonists (ARA-II) in human plasma by liquid-chromatography-tandem mass spectrometry using minimum sample clean-up and investigation of ion suppression.
    Ferreirós N; Dresen S; Alonso RM; Weinmann W
    Ther Drug Monit; 2007 Dec; 29(6):824-34. PubMed ID: 18043483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid and sensitive liquid chromatography tandem mass spectrometry method for the quantification of ambroxol in human plasma.
    Hu W; Xu Y; Liu F; Liu A; Guo Q
    Biomed Chromatogr; 2008 Oct; 22(10):1108-14. PubMed ID: 18506738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects.
    Van Eeckhaut A; Lanckmans K; Sarre S; Smolders I; Michotte Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(23):2198-207. PubMed ID: 19179125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid chromatography-mass spectrometry/mass spectrometry method development for drug metabolism studies: Examining lipid matrix ionization effects in plasma.
    Little JL; Wempe MF; Buchanan CM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Apr; 833(2):219-30. PubMed ID: 16497566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of octreotide and assessment of matrix effects in human plasma using ultra high performance liquid chromatography-tandem mass spectrometry.
    Ismaiel OA; Zhang T; Jenkins R; Karnes HT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(22):2081-8. PubMed ID: 21700513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of bergenin in human plasma by liquid chromatography/tandem mass spectrometry.
    Yu W; Wang Y; Zhang Y; Zhang D; Lan J; Liu Z; Gu J; Fawcett JP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(1-2):33-6. PubMed ID: 19036648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative determination of icotinib in human plasma and urine using liquid chromatography coupled to tandem mass spectrometry.
    Liu D; Jiang J; Hu P; Tan F; Wang Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(30):3781-6. PubMed ID: 19833564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of levetiracetam in human plasma by liquid chromatography-tandem mass spectrometry: application to therapeutic drug monitoring.
    Matar KM
    J Pharm Biomed Anal; 2008 Nov; 48(3):822-8. PubMed ID: 18603399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic investigation of ion suppression and enhancement effects of fourteen stable-isotope-labeled internal standards by their native analogues using atmospheric-pressure chemical ionization and electrospray ionization and the relevance for multi-analyte liquid chromatographic/mass spectrometric procedures.
    Remane D; Wissenbach DK; Meyer MR; Maurer HH
    Rapid Commun Mass Spectrom; 2010 Apr; 24(7):859-67. PubMed ID: 20196193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.